/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Michal Vrablik M.D., Ph.D. is currently a Professor of Internal Medicine at the 1st Faculty of Medicine, Charles University in Prague, the
Czech Republic. His main interests include preventive cardiology, clinical lipidology, CVD risk reduction strategies with special focus on
very high-risk group (e.g. type 2 diabetes), and genetics of lipoprotein metabolism disorders. He is most recently involved in studying cardiovascular prevention
strategies in different population groups and pharmacogenetic studies.
He is the chairman of the Czech Atherosclerosis Society, member of board of the Czech Society of Internal Medicine and the chairman
of the Czech Association of Preventive Cardiology. He serves as the chairman of the European Federation of International Atherosclerosis Society and is a steering committee member of the International Lipid Expert Panel. Dr. Vrablik has authored and co-authored more than 400 papers in peer-reviewed scientific journals.
